Allarity Therapeutics ALLR
NASDAQ ALLR
$1.04 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Non-Current Deffered Revenue (2020 - 2022)

Updated

Allarity Therapeutics' Non-Current Deffered Revenue came in at $1.08 million for Q4 2022, up 10.6% from $979,000 a year earlier.

Analysis

Allarity Therapeutics (ALLR) Non-Current Deffered Revenue (2020 - 2022) Analysis & Trends

Going back to Q4 2020, Allarity Therapeutics' Non-Current Deffered Revenue data covers 6 quarters.

  • Going back by year, Non-Current Deffered Revenue was $979,000 in FY2021 (+11.3%) and $880,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Allarity Therapeutics 1.69 Mn 1.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.08 Mn
Jun 30, 2022 1.03 Mn
Mar 31, 2022 1.01 Mn
Dec 31, 2021 979,000.00
Sep 30, 2021 954,000.00
Dec 31, 2020 880,000.00
API Access

Allarity Therapeutics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ALLR&period=max&api_key=YOUR_API_KEY